Biological Role and Distribution
Cholesterol performs three main functions in the body:
- Structural: A component of cell membranes, regulating the fluidity of the hydrophobic bilayer.
- Transport: Combines with phospholipids to form the surface monolayer of lipoproteins.
- Metabolic: Serves as a precursor for bile acids, steroid hormones, and vitamin D₃.
The body contains approximately 140 g of cholesterol, with the vast majority (93%) located intracellularly. The pool is constantly replenished by endogenous synthesis (~1 g/day) and exogenous dietary intake (0.3–0.5 g/day). Cholesterol is primarily consumed in the formation of bile acids (0.5–0.7 g/day) and is also excreted via feces and sebum.
Digestion and Transport
Dietary fat contains mostly cholesterol esters. In the intestinal lumen, pancreatic cholesterol esterase hydrolyzes them into free cholesterol and fatty acids.
These digestion products are absorbed in mixed micelles. Within enterocytes, re-esterification occurs: ACAT (acyl-CoA:cholesterol acyltransferase) transfers an acyl group from acyl-CoA to the hydroxyl group of cholesterol, forming new cholesterol esters. These esters are then packaged into chylomicrons for transport via the lymphatic system into the bloodstream. Remnant chylomicrons are taken up by the liver via apoE receptors.
De Novo Biosynthesis
Cholesterol synthesis occurs in the cytosol and endoplasmic reticulum of most nucleated cells, predominantly in the liver. The process is most active during the postprandial (absorptive) state.
The source of all 27 carbon atoms is acetyl-CoA, and the reducing equivalents come from NADPH. The pathway involves about 30 reactions. Key steps include:
- Formation of mevalonate: Acetyl-CoA molecules are converted to HMG-CoA. Then, catalyzed by HMG-CoA reductase (consuming NADPH), it is reduced to mevalonate. This is the rate-limiting step of the entire pathway.
- Formation of squalene: Mevalonate molecules are phosphorylated (consuming ATP) and condensed to form the 30-carbon linear hydrocarbon squalene.
Regulation of Synthesis
The primary control point is the enzyme HMG-CoA reductase. Its activity is regulated through several mechanisms:
- Covalent modification: Insulin promotes dephosphorylation of the enzyme, converting it into its active form. Glucagon, conversely, stimulates phosphorylation (via a kinase cascade), inactivating the enzyme. Thus, synthesis is promoted during the fed state and suppressed during fasting.
- Changes in enzyme quantity: Intracellular cholesterol and bile acids suppress transcription of the enzyme's gene and accelerate its proteolytic degradation. Estrogens, conversely, stimulate gene expression.
- Allosteric regulation: Excess end products can also affect enzyme activity.